Items tagged with Diagnostics

Xpert MTB/RIF Ultra: Another advance in TB diagnostics (post)

The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of tuberculosis in decades.

GeneXpert Omni factsheet (post)

Médecins Sans Frontières released a factsheet about GeneXpert Omni expressing concerns on the suitability of the tool for remote settings within low-to-middle income countries. GeneXpert Omni is a single-module point-of-care device produced by Cepheid.

Leading the global market: Stop TB Partnership's GDF secured 41% of TB diagnostic cartridges in 2017 (post)

The expanded use of rapid molecular tests for TB detection and universal drug susceptibility testing is a core component of the Global Plan to End TB

AI technology to examine X-rays, MRIs, CT scans, identify TB patients (post)

Health-tech start-up develops an AI technology that can examine X-rays, MRIs and CT scans, identify patients with TB, stroke or any other disease in no time

(post with image)

Diagnostic tests for active tuberculosis (post with image)

This article descibes the tests that are used to diagnose active TB.

My experience with the health system and TB (post with image)

Lihle Dlamini is the Deputy General Secretary of the Treatment Action Campaign. Her HIV activism started in 2002 when she was diagnosed with TB and experienced the horrors of the South African public health system.

Gene Xpert (post with image)

The Gene Xpert is a new test for tuberculosis. It can find out if a person is infected with TB, and also if the TB bacterium of the person has resistance to one of the common TB drugs, rifampicin.

Drug susceptibility testing – the MGIT system (post with image)

The MGIT system is another way to test for the resistance of TB bacteria to certain TB drugs. Unlike the Genotype MTBDRplus and the INNO-LiPA tests, it uses another way to examine TB bacteria for resistance to drugs.

Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection in United States (document)

This report is aimed at providing guidance to U.S. public health officials, health-care providers, and laboratory workers in the utilization of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Additionally, multiple recommendations addressing quality control, test selection, and medical management after testing are provided.

Page 28 of 35 · Total posts: 0

←First 27 28 29 Last→